Clinical Trials Browser

peginterferon alfa-2b × Dermatologic × 90 days × Clear all

NCT00539591 2025-12-23

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

Phase 2 Active not recruiting

29 enrolled 28 charts

Melanoma